Skip to main content

Table 4 Pathway enrichment and gene ontology of breast cancer related DEGs

From: Genome-scale meta-analysis of breast cancer datasets identifies promising targets for drug development

Category Term Count p-value
GOTERM_BP_FAT Positive regulation of cell differentiation 4 3.9 × 10−3
GOTERM_BP_FAT Gliogenesis 3 4.1 × 10−3
GOTERM_BP_FAT Rhythmic process 3 6.9 × 10−3
GOTERM_BP_FAT Cellular lipid metabolic process 4 7.1 × 10−3
GOTERM_BP_FAT Estrous cycle 2 7.1 × 10−3
GOTERM_BP_FAT Epithelium development 4 7.4 × 10−3
GOTERM_BP_FAT Negative regulation of hydrolase activity 3 1.1 × 10−2
GOTERM_BP_FAT Response to drug 3 1.2 × 10−2
GOTERM_BP_FAT Regulation of oligodendrocyte differentiation 2 1.2 × 10−2
GOTERM_BP_FAT Reproductive structure development 3 1.2 × 10−2
GOTERM_BP_FAT Gland development 3 1.2 × 10−2
GOTERM_BP_FAT Prostaglandin metabolic process 2 1.3 × 10−2
GOTERM_BP_FAT Lipid metabolic process 4 1.4 × 10−2
GOTERM_BP_FAT Neurogenesis 4 1.8 × 10−2
GOTERM_BP_FAT Prostate gland development 2 1.9 × 10−2
GOTERM_BP_FAT Positive regulation of cell death 3 2.5 × 10−2
GOTERM_CC_FAT Extracellular exosome 5 5.9 × 10−3
GOTERM_CC_FAT Extracellular vesicle 5 6.0 × 10−3
GOTERM_CC_FAT Membrane-bound vesicle 5 1.5 × 10−2
GOTERM_CC_FAT Extracellular region 5 3.8 × 10−2
GOTERM_CC_FAT Extrinsic component of membrane 2 8.8 × 10−2
GOTERM_MF_FAT Receptor binding 4 2.2 × 10−2
GOTERM_MF_FAT Enzyme binding 4 3.8 × 10−2
GOTERM_MF_FAT Protein dimerization activity 3 9.2 × 10−2